Osaic Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$169K Sell
7,000
-4,500
-39% -$118K ﹤0.01% 4561
2026
Q1
$323K Buy
11,500
+11,465
+32,757% +$305K ﹤0.01% 3756
2025
Q4
$70 Hold
35
﹤0.01% 7670
2025
Q3
$1.72K Hold
35
﹤0.01% 7182
2025
Q2
$1.82K Buy
+35
New +$816 ﹤0.01% 6968
2021
Q3
Sell
-20
Closed -$3K 7273
2021
Q2
$3K Buy
+20
New +$778 ﹤0.01% 6619

Other funds holding PFE

Osaic Holdings's PFE Position: Q2 2026 in Review

Osaic Holdings increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $7.51M and bringing the position to 2,661,858 shares worth $64.1M. The position accounts for 0.08% of the portfolio, ranked #271.

Osaic Holdings first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $132M in Q4 2021. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Osaic Holdings held 2,661,858 shares of Pfizer worth $64.1M as of Q2 2026.
  • Osaic Holdings bought 287,169 Pfizer shares in Q2 2026, an estimated $7.51M.
  • Pfizer made up 0.08% of Osaic Holdings's portfolio in Q2 2026, its #271 holding.
  • Osaic Holdings first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Pfizer position peaked at $132M in Q4 2021.
  • 2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.